Healthcare Industry News: Bristol-Myers Squibb
News Release - January 18, 2018
Lannett Names Timothy C. Crew To Board Of DirectorsPHILADELPHIA, Jan. 18, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that Timothy C. Crew, the company's recently appointed chief executive officer (CEO), has been added to the Lannett Company Board of Directors. With this appointment, the total number of directors is seven.
Earlier this month, Crew joined Lannett as CEO. He has more than 25 years of experience in the generic and branded pharmaceutical industries, having served in leadership positions with Cipla North America, a global pharmaceutical company based in Mumbai, India, Teva Pharmaceuticals, Dr. Reddy's Laboratories and Bristol-Myers Squibb. Prior to his pharmaceutical roles, Crew served in the United States Army, where he rose to the rank of Captain. Crew earned a Bachelor of Arts degree in economics from Pomona College and a Masters of Business Administration degree from Columbia Business School.
About Lannett Company, Inc.
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit the company's website at www.lannett.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.